We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$601K
2
KNSL icon
Kinsale Capital Group
KNSL
+$335K
3
PXLW icon
Pixelworks
PXLW
+$273K
4
GM icon
General Motors
GM
+$255K
5
MITL
Mitel Networks Corporation
MITL
+$250K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMA
751
DELISTED
Comerica
CMA
– –
-173
Closed -$13K
CMG icon
752
Chipotle Mexican Grill
CMG
$40.8B
– –
-200
Closed -$1K
CNC icon
753
Centene
CNC
$31.3B
– –
-1,138
Closed -$55K
CNI icon
754
Canadian National Railway
CNI
$78.3B
– –
-167
Closed -$14K
COR icon
755
Cencora
COR
$60.3B
– –
-196
Closed -$16K
COTY icon
756
Coty
COTY
$2.33B
– –
-68
Closed -$1K
COST icon
757
Costco
COST
$415B
– –
-480
Closed -$79K
CPT icon
758
Camden Property Trust
CPT
$11.3B
– –
-39
Closed -$4K
CRH icon
759
CRH
CRH
$66.7B
– –
-361
Closed -$14K
CRL icon
760
Charles River Laboratories
CRL
$10.9B
– –
-183
Closed -$20K
CRTO icon
761
Criteo
CRTO
$1.03B
– –
-369
Closed -$15K
CSL icon
762
Carlisle Companies
CSL
$13.6B
– –
-850
Closed -$85K
CTAS icon
763
Cintas
CTAS
$82.4B
– –
-268
Closed -$10K
CTRE icon
764
CareTrust REIT
CTRE
$10.2B
– –
-500
Closed -$10K
CTRA
765
DELISTED
Coterra Energy
CTRA
– –
-73
Closed -$2K
CTSH icon
766
Cognizant
CTSH
$21.5B
– –
-539
Closed -$39K
CUZ icon
767
Cousins Properties
CUZ
$5.29B
– –
-91
Closed -$3K
CVS icon
768
CVS Health
CVS
$137B
– –
-92
Closed -$7K
CVX icon
769
Chevron
CVX
$388B
– –
-367
Closed -$43K
CX icon
770
Cemex
CX
$17.4B
– –
-1,159
Closed -$11K
DAIO icon
771
Data I/O
DAIO
$32M
– –
-7,600
Closed -$76K
DAL icon
772
Delta Air Lines
DAL
$55.9B
– –
-559
Closed -$27K
DAR icon
773
Darling Ingredients
DAR
$9.93B
– –
-1,854
Closed -$32K
DBC icon
774
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
– –
-153
Closed -$2K
DBA icon
775
Invesco DB Agriculture Fund
DBA
$1.26B
– –
-125
Closed -$2K
29 30
31
32 33

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.